Xenetic Biosciences logo

Xenetic Biosciences Share Price (NASDAQ: XBIO)

$2.85

Last updated on

Check the interactive Xenetic Biosciences Stock chart to analyse performance

Xenetic Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.80
    Today's High:$2.94

    Day's Volatility :4.76%

  • 52 Weeks Low:$2.20
    52 Weeks High:$5.27

    52 Weeks Volatility :58.24%

Xenetic Biosciences Stock Returns

PeriodXenetic Biosciences IncIndex (Russel 2000)
3 Months
-12.46%
0.0%
6 Months
-29.06%
0.0%
1 Year
-25.6%
0.0%
3 Years
-60.84%
-4.7%

Xenetic Biosciences Inc Key Stats

Check Xenetic Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.85
Open
$2.8
Today's High
$2.94
Today's Low
$2.8
Market Capitalization
$4.4M
Today's Volume
$21.1K
52 Week High
$5.2683
52 Week Low
$2.2
Revenue TTM
$2.4M
EBITDA
$-5.7M
Earnings Per Share (EPS)
$-2.0
Profit Margin
-126.03%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.83%

Stock Returns calculator for Xenetic Biosciences Stock including INR - Dollar returns

The Xenetic Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenetic Biosciences investment value today

Current value as on today

₹74,966

Returns

₹25,034

(-25.03%)

Returns from Xenetic Biosciences Stock

₹30,318 (-30.32%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Xenetic Biosciences Stock

-50%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Xenetic Biosciences Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Xenetic Biosciences Inc

  • Name

    Holdings %

  • Renaissance Technologies Corp

    1.74%

  • Susquehanna International Group, LLP

    1.65%

  • Citadel Advisors Llc

    1.12%

  • Sachetta LLC

    0.99%

  • Geode Capital Management, LLC

    0.71%

  • JTC Employer Solutions Trustee Ltd

    0.18%

Analyst Recommendation on Xenetic Biosciences Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Xenetic Biosciences(by analysts ranked 0 to 5 stars)

Xenetic Biosciences Share Price Target

What analysts predicted

Upside of 1303.51%

Target:

$40.00

Current:

$2.85

Xenetic Biosciences share price target is $40.00, a slight Upside of 1303.51% compared to current price of $2.85 as per analysts' prediction.

Xenetic Biosciences Stock Insights

  • Price Movement

    In the last 7 days, XBIO stock has moved down by -5.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 648.82K → 589.89K (in $), with an average decrease of 4.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -1.05M → -688.70K (in $), with an average increase of 24.0% per quarter
  • XBIO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 99.5%
  • XBIO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 172.6%
  • Price to Sales

    ForXBIO every $1 of sales, investors are willing to pay $1.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Xenetic Biosciences Technicals Summary

Sell

Neutral

Buy

Xenetic Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Xenetic Biosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xenetic Biosciences Inc logo
-10.42%
-29.06%
-25.6%
-60.84%
-71.34%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Xenetic Biosciences Inc

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression, pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer. Its product pipeline includes XBIO-015 for treating pancreatic carcinoma and solid tumors; and XBIO-020 for treating solid tumors. The company also has partnered with biotechnology and pharmaceutical companies to develop its proprietary drug delivery platform, PolyXen, which as an enabling platform technology for protein and peptide drug delivery. It has collaboration agreements with Belgian Volition SARL Limited to develop NETs-targeted adoptive cell therapies for the treatment of cancer, as well as PJSC Pharmsynthez and Serum Institute of India to develop and launch ErepoXen for the treatment of anemia in chronic kidney disease patients; sublicensing agreement with Takeda Pharmaceutical Co. Ltd; exclusive sublicense agreement with CLS Therapeutics Ltd to develop DNase technology for the treatment of immunotherapies. The company offers under XDNASE, XCART, OncoHist, PolyXen, ErepoXen, and ImuXen trandemarks. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Organization
Xenetic Biosciences
Employees
2
CEO
Mr. James F. Parslow
Industry
Health Technology

Key Management of Xenetic Biosciences Inc

NameTitle
Mr. James F. Parslow
CFO, COO, Interim CEO & Corporate Secretary

Important FAQs about investing in XBIO Stock from India :

What is Xenetic Biosciences share price today?

Xenetic Biosciences share price today is $2.85 as on at the close of the market. Xenetic Biosciences share today touched a day high of $2.94 and a low of $2.80.

What is the 52 week high and 52 week low for Xenetic Biosciences share?

Xenetic Biosciences share touched a 52 week high of $5.27 and a 52 week low of $2.20. Xenetic Biosciences stock price today i.e. is closed at $2.85, lower by 45.9% versus the 52 week high.

How to invest in Xenetic Biosciences Stock (XBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenetic Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenetic Biosciences Shares that will get you 0.5263 shares as per Xenetic Biosciences share price of $2.85 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xenetic Biosciences Stock (XBIO) from India?

Indian investors can start investing in Xenetic Biosciences (XBIO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Xenetic Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Xenetic Biosciences share’s latest price of $2.85 as on August 30, 2025 at 1:29 am IST, you will get 3.5088 shares of Xenetic Biosciences. Learn more about fractional shares .

What are the returns that Xenetic Biosciences has given to Indian investors in the last 5 years?

Xenetic Biosciences stock has given -71.34% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?